VANCOUVER, BRITISH COLUMBIA, November 26, 2021- Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV: PAS) (OTC: PSCBF) (FSE: 6PB-FF)   On October 28, 2021, the Company announced a non-brokered private placement financing of up to 9,000,000 units (each a “Unit”)…

Read More